Literature DB >> 16317159

Zingiberaceous and citrus constituents, 1'-acetoxychavicol acetate, zerumbone, auraptene, and nobiletin, suppress lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 murine macrophages through different modes of action.

Akira Murakami1, Tomohiro Shigemori, Hajime Ohigashi.   

Abstract

In the present study, we explored the suppressive activities of 1'-acetoxychavicol acetate (ACA), auraptene, nobiletin, and zerumbone toward LPS-induced cyclooxygenase (COX)-2 mRNA expression in mouse macrophages and the underlying molecular mechanisms. Pretreatment of RAW264.7 cells with LPS led to the activation of mitogen-activated protein kinase (MAPK)s [p38, extracellular signal-regulated kinase (ERK)1/2, c-Jun NH2-terminal kinase (JNK)1/2] and Akt, together with degradation of the inhibitor of nuclear factor-kappaB (IkappaB)-alpha protein and nuclear translocation of nuclear factor (NF)-kappaB p65, and the resultant activation of activator protein (AP)-1, NF-kappaB, and cAMP-responsive element-binding protein (CREB) transcription factors. ACA abrogated ERK1/2 and JNK1/2, but not p38 MAPK, as well as the activation of those transcription factors. Although it allowed LPS-triggered phosphorylation of those MAPKs and NF-kappaB nuclear translocation, nobiletin suppressed the activation of AP-1, NF-kappaB, and CREB. Zerumbone had no effect on those transcription factors, though it attenuated COX-2 mRNA expression, suggesting that it disrupts the stabilization of COX-2 mRNA. Conversely, zerumbone significantly accelerated spontaneous COX-2 mRNA decay, the potency of which was comparable with that of SB203580, an inhibitor of p38 MAPK, whose activation has key roles in the proinflammatory mRNA stabilization processes. Because SB203580 but not zerumbone suppressed LPS-induced p38 MAPK activation, the molecular targets of zerumbone may be MAPK-activated protein kinase-2 or located downstream. However, auraptene suppressed the expression of COX-2 protein but not mRNA, implying that it targets translation. We propose that these phytochemicals are promising chemopreventive agents for inflammation-associated carcinogenesis. Their use in combination may enhance their efficacy because of their different modes of action.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16317159     DOI: 10.1093/jn/135.12.2987S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  21 in total

Review 1.  Cancer prevention and therapy through the modulation of the tumor microenvironment.

Authors:  Stephanie C Casey; Amedeo Amedei; Katia Aquilano; Asfar S Azmi; Fabian Benencia; Dipita Bhakta; Alan E Bilsland; Chandra S Boosani; Sophie Chen; Maria Rosa Ciriolo; Sarah Crawford; Hiromasa Fujii; Alexandros G Georgakilas; Gunjan Guha; Dorota Halicka; William G Helferich; Petr Heneberg; Kanya Honoki; W Nicol Keith; Sid P Kerkar; Sulma I Mohammed; Elena Niccolai; Somaira Nowsheen; H P Vasantha Rupasinghe; Abbas Samadi; Neetu Singh; Wamidh H Talib; Vasundara Venkateswaran; Richard L Whelan; Xujuan Yang; Dean W Felsher
Journal:  Semin Cancer Biol       Date:  2015-04-10       Impact factor: 15.707

2.  Downregulation of programmed cell death 4 by inflammatory conditions contributes to the generation of the tumor promoting microenvironment.

Authors:  Michiko Yasuda; Tobias Schmid; Daniela Rübsamen; Nancy H Colburn; Kazuhiro Irie; Akira Murakami
Journal:  Mol Carcinog       Date:  2010-09       Impact factor: 4.784

3.  Nobiletin-Ameliorated Lipopolysaccharide-Induced Inflammation in Acute Lung Injury by Suppression of NF-κB Pathway In Vivo and Vitro.

Authors:  Weifeng Li; Ruoqi Zhao; Xiumei Wang; Fang Liu; Jinmeng Zhao; Qing Yao; Wenbing Zhi; Zehong He; Xiaofeng Niu
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

4.  Anti-inflammatory effect of auraptene extracted from trifoliate orange (Poncirus trifoliate) on LPS-stimulated RAW 264.7 cells.

Authors:  Huiqing Yan; Zhaocheng Ma; Shu'ang Peng; Xiuxin Deng
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

5.  Citrus peel polymethoxyflavones nobiletin and tangeretin suppress LPS- and IgE-mediated activation of human intestinal mast cells.

Authors:  Yvonne Hagenlocher; Katharina Feilhauer; Michael Schäffer; Stephan C Bischoff; Axel Lorentz
Journal:  Eur J Nutr       Date:  2016-03-28       Impact factor: 5.614

6.  Anti-inflammatory effect of certain dimethoxy flavones.

Authors:  Kamalakannan Pandurangan; Vidyalakshmi Krishnappan; Viswanathan Subramanian; Ramaswamy Subramanyan
Journal:  Inflammopharmacology       Date:  2015-08-07       Impact factor: 4.473

7.  Protective Effects of Nobiletin Against Endotoxic Shock in Mice Through Inhibiting TNF-α, IL-6, and HMGB1 and Regulating NF-κB Pathway.

Authors:  Weifeng Li; Xiumei Wang; Xiaofeng Niu; Hailin Zhang; Zehong He; Yu Wang; Wenbing Zhi; Fang Liu
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

8.  Citrus auraptene suppresses cyclin D1 and significantly delays N-methyl nitrosourea induced mammary carcinogenesis in female Sprague-Dawley rats.

Authors:  Prasad Krishnan; Karen J Yan; David Windler; Jesse Tubbs; Robert Grand; Benjamin D L Li; C Marcelo Aldaz; Jerry McLarty; Heather E Kleiner-Hancock
Journal:  BMC Cancer       Date:  2009-07-29       Impact factor: 4.430

9.  1'-Acetoxychavicol acetate isolated from Alpinia galanga ameliorates ovalbumin-induced asthma in mice.

Authors:  Joung-Wook Seo; Soon-Chang Cho; Sang-Joon Park; Eun-Ji Lee; Jong-Hwa Lee; Sang-Seop Han; Byeong Sik Pyo; Dae-Hun Park; Bong-Hee Kim
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

10.  Non-specific protein modifications by a phytochemical induce heat shock response for self-defense.

Authors:  Kohta Ohnishi; Shinya Ohkura; Erina Nakahata; Akari Ishisaka; Yoshichika Kawai; Junji Terao; Taiki Mori; Takeshi Ishii; Tsutomu Nakayama; Noriyuki Kioka; Shinya Matsumoto; Yasutaka Ikeda; Minoru Akiyama; Kazuhiro Irie; Akira Murakami
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.